168 related articles for article (PubMed ID: 11724756)
1. Therapeutic potential of a novel synthetic selectin blocker, OJ-R9188, in allergic dermatitis.
Ikegami-Kuzuhara A; Yoshinaka T; Ohmoto H; Inoue Y; Saito T
Br J Pharmacol; 2001 Dec; 134(7):1498-504. PubMed ID: 11724756
[TBL] [Abstract][Full Text] [Related]
2. A novel selectin blocker alleviates oxidative stress of lung reperfusion injury.
Yoshimura T; Kawashima M; Nakamura T; Isowa N; Bando T; Hasegawa S; Kondo H; Toyokuni S; Wada H
J Surg Res; 2001 Nov; 101(1):91-8. PubMed ID: 11676561
[TBL] [Abstract][Full Text] [Related]
3. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin.
Beauharnois ME; Lindquist KC; Marathe D; Vanderslice P; Xia J; Matta KL; Neelamegham S
Biochemistry; 2005 Jul; 44(27):9507-19. PubMed ID: 15996105
[TBL] [Abstract][Full Text] [Related]
4. Role of selectins on IgE-mediated skin reaction.
Wada Y; Kuzuhara A; Hanamura M; Kida R; Yoshinaka T; Saito T
Br J Pharmacol; 2000 Dec; 131(8):1531-6. PubMed ID: 11139428
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory activity of monomeric and polymeric selectin ligands].
Ushakova NA; Preobrazhenskaia ME; Nifant'ev NE; Usov AI; Pochechueva TV; Galanina OE; Bovin NV
Vopr Med Khim; 1999; 45(5):375-83. PubMed ID: 10635531
[TBL] [Abstract][Full Text] [Related]
6. [Effects of mannose derivatives on development of selectin-dependent peritoneal inflammation in rats and mice].
Ushakova NA; Probrazhenskaia ME; Nifant'ev NE; Voznyĭ IaV; Pochechueva TV; Bovin NV
Vopr Med Khim; 2001; 47(5):491-7. PubMed ID: 11766259
[TBL] [Abstract][Full Text] [Related]
7. BMS-190394, a selectin inhibitor, prevents rat cutaneous inflammatory reactions.
Todderud G; Nair X; Lee D; Alford J; Davern L; Stanley P; Bachand C; Lapointe P; Marinier A; Martel A; Menard M; Wright JJ; Bajorath J; Hollenbaugh D; Aruffo A; Tramposch KM
J Pharmacol Exp Ther; 1997 Sep; 282(3):1298-304. PubMed ID: 9316838
[TBL] [Abstract][Full Text] [Related]
8. P- and E-selectins recognize sialyl 6-sulfo Lewis X, the recently identified L-selectin ligand.
Ohmori K; Kanda K; Mitsuoka C; Kanamori A; Kurata-Miura K; Sasaki K; Nishi T; Tamatani T; Kannagi R
Biochem Biophys Res Commun; 2000 Nov; 278(1):90-6. PubMed ID: 11071860
[TBL] [Abstract][Full Text] [Related]
9. Selectin/glycoconjugate binding assays for the identification and optimization of selectin antagonists.
Weitz-Schmidt G; Gong KW; Wong CH
Anal Biochem; 1999 Aug; 273(1):81-8. PubMed ID: 10452802
[TBL] [Abstract][Full Text] [Related]
10. Studies on selectin blockers. 4. Structure-function relationships of sulfated sialyl Lewis X hexasaccharide ceramides toward E-, P-, and L-selectin binding.
Yoshino K; Ohmoto H; Kondo N; Tsujishita H; Hiramatsu Y; Inoue Y; Kondo H
J Med Chem; 1997 Feb; 40(4):455-62. PubMed ID: 9046335
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory effects of a selectin ligand mimetic, TBC-1269, are not a result of competitive inhibition of leukocyte rolling in vivo.
Hicks AE; Abbitt KB; Dodd P; Ridger VC; Hellewell PG; Norman KE
J Leukoc Biol; 2005 Jan; 77(1):59-66. PubMed ID: 15466915
[TBL] [Abstract][Full Text] [Related]
12. Analysis of bovine gamma delta T cell interactions with E-, P-, and L-selectin. Characterization of lymphocyte on lymphocyte rolling and the effects of O-glycoprotease.
Jutila MA; Kurk S
J Immunol; 1996 Jan; 156(1):289-96. PubMed ID: 8598476
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of sulphated hyaluronic acid, a potential selectin-blocking agent, on experimental progressive mesangial proliferative glomerulonephritis.
Matsuda M; Shikata K; Shimizu F; Suzuki Y; Miyasaka M; Kawachi H; Kawashima H; Wada J; Sugimoto H; Shikata Y; Ogawa D; Tojo SJ; Akima K; Makino H
J Pathol; 2002 Nov; 198(3):407-14. PubMed ID: 12375274
[TBL] [Abstract][Full Text] [Related]
14. L- and P-selectins collaborate to support leukocyte rolling in vivo when high-affinity P-selectin-P-selectin glycoprotein ligand-1 interaction is inhibited.
Ridger VC; Hellewell PG; Norman KE
Am J Pathol; 2005 Mar; 166(3):945-52. PubMed ID: 15743805
[TBL] [Abstract][Full Text] [Related]
15. Monomeric and multimeric blockers of selectins: comparison of in vitro and in vivo activity.
Ushakova NA; Preobrazhenskaya ME; Bird MI; Priest R; Semenov AV; Mazurov AV; Nifantiev NE; Pochechueva TV; Galanina OE; Bovin NV
Biochemistry (Mosc); 2005 Apr; 70(4):432-9. PubMed ID: 15892609
[TBL] [Abstract][Full Text] [Related]
16. High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome.
Hashida N; Ohguro N; Yamazaki N; Arakawa Y; Oiki E; Mashimo H; Kurokawa N; Tano Y
Exp Eye Res; 2008 Jan; 86(1):138-49. PubMed ID: 18036523
[TBL] [Abstract][Full Text] [Related]
17. Role of selectins in the intestinal epithelial migration of eosinophils.
Michail S; Mezoff E; Abernathy F
Pediatr Res; 2005 Oct; 58(4):644-7. PubMed ID: 16189187
[TBL] [Abstract][Full Text] [Related]
18. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins.
Wang L; Brown JR; Varki A; Esko JD
J Clin Invest; 2002 Jul; 110(1):127-36. PubMed ID: 12093896
[TBL] [Abstract][Full Text] [Related]
19. Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitment.
Borsig L; Wang L; Cavalcante MC; Cardilo-Reis L; Ferreira PL; Mourão PA; Esko JD; Pavão MS
J Biol Chem; 2007 May; 282(20):14984-91. PubMed ID: 17371880
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interactions of the two classes of ligand, sialyl-Lewis(a/x) fuco-oligosaccharides and short sulpho-motifs, with the P- and L-selectins: implications for therapeutic inhibitor designs.
Galustian C; Childs RA; Stoll M; Ishida H; Kiso M; Feizi T
Immunology; 2002 Mar; 105(3):350-9. PubMed ID: 11918697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
